Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed Aug 13, 2025 · 10-Q · 44 days after period end · 0001641172-25-023568
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | $277.86K | -$209.84K | -$6.76M | $16.01M |
| EPS Diluted | $0.00 | $0.00 | — | $0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 13, 2025 · 44 d after period end
